Drug intelligence / Profile preview

amoxicillin-clavulanate + doxycycline

Development stage
Preclinical
Lead developer
GSK
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Amoxicillin-clavulanate + doxycycline is an antibiotic combination therapy consisting of two different classes of antibiotics. Amoxicillin-clavulanate combines amoxicillin (a penicillin-type antibiotic effective against gram-positive and gram-negative bacteria) with clavulanate (a beta-lactamase inhibitor that prevents bacterial enzymes from inactivating amoxicillin). Doxycycline is a tetracycline-class antibiotic that works by inhibiting bacterial protein synthesis.

This combination is generally not recommended as a first-line treatment option because tetracycline antibiotics (like doxycycline) can reduce the effectiveness of penicillin-type antibiotics (like amoxicillin). Laboratory studies have shown that when used together, doxycycline may interfere with amoxicillin's bactericidal activity, potentially making amoxicillin less effective.

However, in specific clinical scenarios such as recurrent/progressive periodontitis, sequential administration (using one antibiotic followed by the other) has shown some benefit compared to single antibiotic regimens.

02

Targets

Beyond the preview

Go deeper on amoxicillin-clavulanate + doxycycline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amoxicillin-clavulanate + doxycycline.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call